CURAEGIS TECHNOLOGIES, INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2017-12-06: Form 8-K; Period of report 2017-11-30; Description 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities; 8.01 Other Events; Details 1.01.
- 2017-11-14: Form 8-K; Period of report 2017-11-08; Description 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities; Details 1.01.
- 2017-10-18: Form 8-K; Period of report 2017-10-18; Description 8.01 Other Events; Details 8.01.
- 2017-10-05: Form 8-K; Period of report 2017-10-05; Description 8.01 Other Events; Details 8.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2017-12-06 | 8-K | 2017-11-30 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities; 8.01 Other Events | 1.01 On November 30, 2017, CurAegis Technologies, Inc. (the “Company”) entered into Amendment No. 2 to Securities Purchase Agreement, made as of November 30, 2017, by and between the Company and the investors signatory thereto (the “Amendment”). 8.01 On December 6, 2017, Richard A. Kaplan, the Company’s Chief Executive Officer provided an update of the Company’s recent events. | crgs20171206_8k.htm |
| 2017-11-14 | 8-K | 2017-11-08 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities | 1.01 This Current Report on Form 8K of CurAegis Technologies, Inc. (“the Company”) reports the November 8, 2017 investments made by Thomas Bonadio, a director of the Company and Richard A. Kaplan, the Company’s Chief Executive Officer and a director. | crgs20171113_8k.htm |
| 2017-10-18 | 8-K | 2017-10-18 | 8.01 Other Events | 8.01 We face a variety of risks inherent in perfecting our technologies to production-ready models and in our efforts to commercialize these technologies to generate revenues and profits. | crgs20171018_8k.htm |
| 2017-10-05 | 8-K | 2017-10-05 | 8.01 Other Events | 8.01 On October 5, 2017, the Company issued a press release providing an update of the Company’s recent events. | crgs20171005_8k.htm |
| 2017-08-30 | 8-K | 2017-08-24 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities | 1.01 This Current Report on Form 8K reports the August 24, 2017 investment by E. Philip Saunders a director of the Company. | crgs20170829_8k.htm |
| 2017-08-14 | 8-K | 2017-08-10 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities | 1.01 On August 10, 2017, Richard A. Kaplan, chief executive officer and director of the Company, invested $125,000 in the Company’s 6% Senior Convertible Promissory Notes and Warrants (“the 2017 Convertible Notes”). | crgs20170814_8k.htm |
| 2017-07-14 | 8-K | 2017-07-12 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities | 1.01 On July 12, 2017, Richard A. Kaplan, chief executive officer and director of CurAegis Technologies, Inc. (the “Company”), entered into a Securities Purchase Agreement (the “2017 SPA”) with the Company, pursuant to which Mr. Kaplan invested $100,000 in the Company’s 6% Senior Convertible Promissory Notes (“2017 Convertible Notes”) and Common Stock Purchase Warrants (“2017 Warrants”). | crgs20170714_8k.htm |
| 2017-06-15 | 8-K | 2017-06-15 | 5.07 Submission of Matters to a Vote of Security Holders; 8.01 Other Events | 5.07 On June 14, 2017, CurAegis Technologies, Inc. held its annual shareholders meeting (“Annual Meeting”) for its common and voting preferred shareholders. 8.01 Previously in advance of the Annual Meeting, the board of directors met and took the actions described below. | crgs20170615_8k.htm |
| 2017-05-30 | 8-K | 2017-05-30 | 8.01 Other Events | 8.01 On May 30, 2017, the Company issued a press release providing an update of the Company’s recent events. | crgs20170530_8k.htm |
| 2017-03-17 | 8-K | 2017-03-17 | 8.01 Other Events | 8.01 CurAegis personnel will be attending and presenting at the 10th International Conference on Managing Fatigue March 20-24, 2017 in San Diego, CA. | crgs20170317_8k.htm |
| 2017-01-25 | 8-K | 2017-01-25 | 8.01 Other Events | 8.01 On January 25, 2017, the Company issued a press release providing an update of the Company’s recent events. | crgs20170125_8k.htm |